NCT07713732
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07713732
Title TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Treeline Biosciences, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.